AMN AMN HEALTHCARE SERVICES INC
Services-Help Supply Services · NYSE · SEC CIK 1142750 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY29.5%
TTM net income YoY139.6%
TTM EPS YoY138.1%
Revenue 3-yr CAGR-5.0%
Net income 3-yr CAGR-27.0%
Margins
Gross margin28.4%
Operating margin5.8%
Net margin3.1%
FCF margin9.3%
EBITDA margin9.6%
Returns
ROE15.4%
ROA4.9%
ROIC (approx.)24.2%
Asset turnover1.59x
Leverage & solvency
Liabilities / assets66.2%
Debt / equity0.00x
Current ratio1.21x
Interest coverage6.08x
Cash quality & payout
Operating cash flow / net income3.31x
Accruals ratio-11.4%
Payout ratio—
Capex / revenue1.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $2.73B | $2.98B |
| Cost of revenue | $1.96B | $2.06B |
| Gross profit | $774.06M | $919.38M |
| SG&A expense | $593.02M | $632.49M |
| Operating income | -$55.47M | -$102.67M |
| Interest expense | $45.59M | $69.90M |
| Pretax income | -$101.06M | -$172.57M |
| Income tax | -$5.36M | -$25.59M |
| Net income | -$95.70M | -$146.98M |
| EBITDA | $101.13M | $71.11M |
| EPS (basic) | -2.48 | -3.85 |
| EPS (diluted) | -2.48 | -3.85 |
| Weighted avg. shares (diluted) | 38.52M | 38.19M |
| Balance sheet | ||
| Cash & equivalents | $33.97M | $89.31M |
| Receivables | $382.56M | $437.82M |
| Current assets | $545.38M | $594.91M |
| PP&E, net | $136.36M | $186.27M |
| Goodwill | $755.81M | $897.46M |
| Intangibles | $283.53M | $381.36M |
| Total assets | $2.09B | $2.42B |
| Current liabilities | $577.61M | $545.78M |
| Long-term debt | $767.05M | $1.06B |
| Total debt | $767.05M | $1.06B |
| Total liabilities | $1.45B | $1.71B |
| Shareholders' equity | $642.11M | $706.62M |
| Net debt | $733.08M | $966.57M |
| Shares outstanding | 38.44M | 38.08M |
| Cash flow statement | ||
| Operating cash flow | $269.46M | $320.42M |
| Capital expenditure | $35.63M | $80.89M |
| Free cash flow | $233.83M | $239.53M |
| Investing cash flow | $4.30M | -$79.94M |
| Financing cash flow | -$295.89M | -$259.45M |
| Depreciation & amortization | $156.60M | $173.78M |
| Stock-based compensation | $30.68M | $23.32M |
| Share buybacks | $0 | $0 |
Free plan shows the latest 2 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.